Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): a prospective study from the Belgian Hematology Society (BHS)

TY - JOUR

T1 - Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): a prospective study from the Belgian Hematology Society (BHS)

AU - Poiré, Xavier

AU - Graux, Carlos

AU - Ory, Aurélie

AU - Herman, Julie

AU - Baron, Frédéric

AU - Schoemans, Hélène

AU - Lewalle, Philippe

AU - De Becker, Ann

AU - Deeren, Dries

AU - Berneman, Zwi

AU - Kerre, Tessa

AU - Zachée, Pierre

AU - Selleslag, Dominik

AU - Beguin, Yves

N1 - Funding Information: FB has received travel grants and/or speaker honoraria from Celgene, AbbVie, Novartis, Pfizer and Sanofi. HS has received travel grants and/or speaker/advisor honoraria from Incyte, Janssen, Novartis, Jazz Pharmaceuticals, Takeda Celgene, AbbVie, MSD, and Therakos. YB has received travel grants and/or speaker/consulting honoraria from Celgene, AbbVie, Novartis, Pfizer, Janssens-Cilag, Amgen and Sanofi. The study was supported by a grant from Celgene Inc. Copyright: Copyright 2022 Elsevier B.V., All rights reserved.

PY - 2022/1

Y1 - 2022/1

UR - http://www.scopus.com/inward/record.url?scp=85116396138&partnerID=8YFLogxK

U2 - 10.1038/s41409-021-01464-x

DO - 10.1038/s41409-021-01464-x

M3 - Article

VL - 57

SP - 116

EP - 118

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 1

ER -